Cargando…
Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
Although elevated intraocular pressure (IOP) remains the major risk factor in glaucoma, neurodegenerative processes continue despite effective IOP lowering. Altered α-synuclein antibody (Abs) levels have been reported to play a crucial role. This study aimed at identifying whether α-synuclein Abs ar...
Autores principales: | Teister, J., Anders, F., Beck, S., Funke, S., von Pein, H., Prokosch, V., Pfeiffer, N., Grus, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524683/ https://www.ncbi.nlm.nih.gov/pubmed/28740252 http://dx.doi.org/10.1038/s41598-017-06702-1 |
Ejemplares similares
-
Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
por: Anders, Fabian, et al.
Publicado: (2017) -
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma
por: Gramlich, Oliver W., et al.
Publicado: (2016) -
The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
por: Anders, Fabian, et al.
Publicado: (2017) -
A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma
por: Tonner, Henrik, et al.
Publicado: (2022) -
Glaucoma related Proteomic Alterations in Human Retina Samples
por: Funke, Sebastian, et al.
Publicado: (2016)